Company Description
Ambiq Micro, Inc. provides ultra-low-power semiconductor solutions in the United States, Europe, Asia, and internationally.
It develops sub-threshold power-optimized technology (SPOT) platform which is designed to reduce power consumption of battery- and wireline-powered devices alike.
The company’s flagship products include Apollo family of products which pair rich peripheral sets with host processors capable of software-based AI computations or vector-accelerated AI computations; and Atomiq, targeting AI applications to provide AI acceleration along with new memory innovations.
It also provides AmbiqSuite Software Development Kit (SDK), which provides firmware and drivers required to operate systems-on-chips (SoC); software modules, such as graphiqSPOT for graphics and display management, blueSPOT for Bluetooth communications, secureSPOT for managing security, and others; and AI enablement software.
The company serves various markets requiring on-device and real-time AI, including smartwatches and fitness trackers, augmented and virtual reality (AR/VR) glasses, smart rings, digital health monitors, security systems and access control, livestock tracking, crop monitoring, and factory automation.
It offers its products through internal direct sales force, and through a network of distributors and sales representatives.
The company was formerly known as Cubiq Microchip, Inc. and changed its name to Ambiq Micro, Inc. in October 2012.
The company was incorporated in 2010 and is based in Austin, Texas.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 30, 2025 |
| Industry | Semiconductors |
| Sector | Technology |
| Employees | 202 |
| CEO | Fumihide Esaka |
Contact Details
Address: 6500 River Place Boulevard, Building 7 Austin, Texas 78730 United States | |
| Phone | 512 879 2850 |
| Website | ambiq.com |
Stock Details
| Ticker Symbol | AMBQ |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $24.00 |
| CIK Code | 1500412 |
| CUSIP Number | 023193105 |
| ISIN Number | US0231931058 |
| Employer ID | 27-1911389 |
| SIC Code | 3674 |
Key Executives
| Name | Position |
|---|---|
| Fumihide Esaka | Chief Executive Officer and Director |
| Dr. Scott McLean Hanson Ph.D. | Co-Founder, Chief Technology Officer, Secretary and Director |
| Jeffrey G. Winzeler | Chief Financial Officer |
| Sean Chihhsiang Chen | President and Chief Operating Officer |
| David Blaauw | Co-Founder |
| Dr. Dennis Sylvester | Co-Founder |
| Lisa Standley | Senior Director of Finance and Administration |
| Charlene Wan | Vice President of Corporate Marketing and Investor Relations |
| Michele Connors | General Counsel |
| Aaron Grassian | Executive Vice President of Global Sales and Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 5, 2026 | 10-K | Annual Report |
| Mar 5, 2026 | 8-K | Current Report |
| Jan 26, 2026 | 424B4 | Prospectus |
| Jan 23, 2026 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| Jan 22, 2026 | EFFECT | Notice of Effectiveness |
| Jan 21, 2026 | 8-K | Current Report |
| Jan 21, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jan 8, 2026 | 8-K | Current Report |
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Nov 6, 2025 | 8-K | Current Report |